Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Ravaud

Showing results (181-190 of 501) with videos related to

Pageof 51
Sort By:
Trials|May 6, 2009
Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary interventionMorgane Ethgen, Isabelle Boutron, Philippe Gabriel Steg, et al.
BMJ Medicine|March 13, 2023
Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of <b>patients</b> with long covid: target trial emulation based on ComPaRe e-cohortViet-Thi Tran, Elodie Perrodeau, Julia Saldanha, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 14, 2023
Trajectories of the evolution of post-COVID-19 condition, up to two years after symptoms onsetClemence Servier, Raphael Porcher, Isabelle Pane, et al.
JAMA Network Open|January 13, 2021
Evaluation of Patient Willingness to Adopt Remote Digital Monitoring for Diabetes ManagementTheodora Oikonomidi, Philippe Ravaud, Emmanuel Cosson, et al.
JAMA|August 14, 2014
Association between analytic strategy and estimates of treatment outcomes in meta-analysesAgnes Dechartres, Douglas G Altman, Ludovic Trinquart, et al.
Annals of Family Medicine|September 14, 2016
Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by PhysiciansStéphanie Sidorkiewicz, Viet-Thi Tran, Cécile Cousyn, et al.
Journal of Clinical Epidemiology|August 14, 2010
Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessedAgnes Dechartres, Pierre Charles, Sally Hopewell, et al.
JAMA|September 3, 2009
Comparison of registered and published primary outcomes in randomized controlled trialsSylvain Mathieu, Isabelle Boutron, David Moher, et al.
Plos One|November 21, 2012
Case-only designs in pharmacoepidemiology: a systematic reviewSandra Nordmann, Lucie Biard, Philippe Ravaud, et al.
BMC Medicine|November 22, 2012
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressantsAli A Alkhafaji, Ludovic Trinquart, Gabriel Baron, et al.
Pageof 51

Showing results (181-190 of 501) with videos related to

Sort By:
Pageof 51
Trials|May 6, 2009
Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary interventionMorgane Ethgen, Isabelle Boutron, Philippe Gabriel Steg, et al.
BMJ Medicine|March 13, 2023
Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of <b>patients</b> with long covid: target trial emulation based on ComPaRe e-cohortViet-Thi Tran, Elodie Perrodeau, Julia Saldanha, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 14, 2023
Trajectories of the evolution of post-COVID-19 condition, up to two years after symptoms onsetClemence Servier, Raphael Porcher, Isabelle Pane, et al.
JAMA Network Open|January 13, 2021
Evaluation of Patient Willingness to Adopt Remote Digital Monitoring for Diabetes ManagementTheodora Oikonomidi, Philippe Ravaud, Emmanuel Cosson, et al.
JAMA|August 14, 2014
Association between analytic strategy and estimates of treatment outcomes in meta-analysesAgnes Dechartres, Douglas G Altman, Ludovic Trinquart, et al.
Annals of Family Medicine|September 14, 2016
Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by PhysiciansStéphanie Sidorkiewicz, Viet-Thi Tran, Cécile Cousyn, et al.
Journal of Clinical Epidemiology|August 14, 2010
Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessedAgnes Dechartres, Pierre Charles, Sally Hopewell, et al.
JAMA|September 3, 2009
Comparison of registered and published primary outcomes in randomized controlled trialsSylvain Mathieu, Isabelle Boutron, David Moher, et al.
Plos One|November 21, 2012
Case-only designs in pharmacoepidemiology: a systematic reviewSandra Nordmann, Lucie Biard, Philippe Ravaud, et al.
BMC Medicine|November 22, 2012
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressantsAli A Alkhafaji, Ludovic Trinquart, Gabriel Baron, et al.
Pageof 51